Intravenous-to-oral antibiotic switch therapy - A cost-effective approach

被引:35
|
作者
Cunha, BA [1 ]
机构
[1] SUNY STONY BROOK,SCH MED,STONY BROOK,NY 11794
关键词
D O I
10.3810/pgm.1997.04.199
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Every attempt should be made to switch hospitalized infectious-disease patients from intravenous to oral antibiotic therapy as soon as clinical improvement makes it possible. In addition to tremendous cost savings, the advantages of oral therapy are impressive and include a decrease in the number of nosocomial infections, shorter length of hospital stay, and lower incidence of intravenous-line infections. The main barrier to the acceptance of switch therapy is a lack of understanding of its efficacy, safety, and cost advantages. The wide-scale institution of managed care has resulted in the dawning of the era of oral antimicrobial therapy. Everything from infective endocarditis in intravenous drug abusers to neuroborreliosis may be treated effectively by the oral route.
引用
收藏
页码:111 / &
页数:10
相关论文
共 50 条
  • [1] Pharmacovigilance of intravenous-to-oral antibiotic switch therapy: Development and validation of a clinical rule
    Paans, J. G.
    van Meijl, F. T.
    Scheepers-Hoeks, A. M. J. W.
    Mestrom, M.
    Roos, A. N.
    Wulf, M. W. H.
    Korsten, H. H. M.
    Grouls, R. J. E.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 740 - 741
  • [2] Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia
    Cunha, BA
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (05): : 412 - 413
  • [3] Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
    Van der Linden, Paul
    Natsch, Stephanie
    Van de Garde, Ewoudt
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] PHARMACOKINETICS OF PENICILLIN ANTIBIOTICS: INTRAVENOUS-TO-ORAL SWITCH THERAPY
    Marusic, Alenka Premus
    Locatelli, Igor
    Mrhar, Ales
    [J]. ZDRAVSTVENO VARSTVO, 2010, 49 (04): : 211 - 218
  • [5] Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units
    Juliano Gasparetto
    Felipe Francisco Tuon
    Dayana dos Santos Oliveira
    Tiago Zequinao
    Gabriel Rammert Pipolo
    Gabriel Velloso Ribeiro
    Paola Delai Benincá
    June Alisson Westarb Cruz
    Thyago Proenca Moraes
    [J]. BMC Infectious Diseases, 19
  • [6] Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units
    Gasparetto, Juliano
    Tuon, Felipe Francisco
    Oliveira, Dayana dos Santos
    Zequinao, Tiago
    Pipolo, Gabriel Rammert
    Ribeiro, Gabriel Velloso
    Beninca, Paola Delai
    Westarb Cruz, June Alisson
    Moraes, Thyago Proenca
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [7] Improving intravenous-to-oral antibiotic switch in children: a team-based audit and implementation approach
    McMullan, Brendan Joseph
    Mahony, Michelle
    Java, Lolita
    Mostaghim, Mona
    Plaister, Michael
    Wu, Camille
    White, Sophie
    Yazidi, Laila Al
    Martin, Erica
    Bryant, Penelope
    Thursky, Karin A.
    Buono, Evette
    [J]. BMJ OPEN QUALITY, 2021, 10 (01)
  • [8] Intravenous to oral antibiotic switch therapy
    Cunha, BA
    [J]. DRUGS OF TODAY, 2001, 37 (05) : 311 - 319
  • [9] Intravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives
    Srinivas, Nuggehally R.
    [J]. FUTURE MICROBIOLOGY, 2017, 12 (10) : 847 - 851
  • [10] Factors Influencing Intravenous-to-Oral Antibiotic Switch among Private Healthcare Providers in Malaysia
    Chua, H. M.
    Islahudin, F.
    Tahir, N. A. Mohd
    Azman, N. J.
    Zein, Z. Wan
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 (04) : 698 - +